Period18 Mar 2024

Media coverage

9

Media coverage

  • TitleUnited Therapeutics continues to outperform Gilead
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to outperform Amgen
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to outperform Vertex Pharmaceuticals
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Regeneron
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Gilead
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Regeneron
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Amgen
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Vertex Pharmaceuticals
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein
  • TitleUnited Therapeutics- 7 Reasons Investors Remain Bullish (and 1 Reason Why Bearish)
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date18/03/24
    PersonsJeffrey Klein